IRIS
DE MARTINO, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 213
AS - Asia 202
EU - Europa 74
AF - Africa 15
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 211
SG - Singapore 84
VN - Vietnam 54
CN - Cina 34
NL - Olanda 31
HK - Hong Kong 30
RU - Federazione Russa 17
CI - Costa d'Avorio 15
IT - Italia 11
BR - Brasile 7
SE - Svezia 7
DE - Germania 3
CA - Canada 2
CL - Cile 2
HR - Croazia 2
EU - Europa 1
FI - Finlandia 1
GB - Regno Unito 1
UA - Ucraina 1
Totale 514
Salva come PNG Salva come JPEG
Città #
Dong Ket 54
Singapore 45
Amsterdam 31
Hong Kong 30
Millbury 28
Santa Clara 23
Chandler 17
Princeton 15
Nanjing 14
Des Moines 11
Naples 5
Norwalk 5
The Dalles 5
Seattle 4
Shenyang 4
Beijing 3
Hebei 3
Jiaxing 3
Changsha 2
Moscow 2
Nanchang 2
São Paulo 2
Tianjin 2
Whitby 2
Zagreb 2
Ashburn 1
Bila Tserkva 1
Colorado 1
Falkenstein 1
Frankfurt am Main 1
Genoa 1
Helsinki 1
Itaquaquecetuba 1
João Pessoa 1
London 1
Nuremberg 1
Praia Grande 1
Salerno 1
São João do Manhuaçu 1
Wilmington 1
Totale 329
Salva come PNG Salva come JPEG
Nome #
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study 54
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? 44
VEGF plasma level variations in duloxetine-treated patients with major depression 43
Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report 42
The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? 37
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management 37
BDNF plasma levels variations in major depressed patients receiving duloxetine 34
NGF serum levels variations in major depressed patients receiving duloxetine 33
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds 32
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? 32
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects 31
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation 29
Electroretinographic (ERG) assessment in Major Depressive Disorder (MDD) patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? 28
Erratum: Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: Relationship with cyclothymic temperament and "therapeutic sensation seeking" in response towards subjective intolerance to pain" (Journal of Affective Disorders (2013) 151:2 (596-604) DOI:10.1016/j.jad.2013.07.004) 28
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance 28
Totale 532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 2 1 0
2020/202160 1 0 0 0 0 1 0 0 0 0 2 56
2021/202273 0 0 0 2 0 5 0 5 0 2 20 39
2022/202395 15 4 0 0 6 4 0 10 13 30 10 3
2023/202462 5 11 6 3 2 0 1 16 0 3 10 5
2024/2025190 24 29 2 3 31 4 40 38 19 0 0 0
Totale 532